Replimune Group Inc (REPL) Outlook Starting To Look Brighter?
Replimune Group Inc (REPL) concluded trading on Thursday at a closing price of $7.66, with 2.66 million shares of worth about $20.35 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -59.26% during that period and on Thursday the price saw a gain of […]
Analysts Update Their Price Forecasts For Replimune Group Inc (REPL)
T. Rowe Price Associates, Inc. has recently announced that it has increased stake in Replimune Group Inc (NASDAQ:REPL) by 0.94%. After grabbing 5.67 million shares, the institutional investor is now in possession of 52966.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 9.60% having worth around $63.35 million. […]
These Numbers Could Change Investor Views For Replimune Group Inc (NASDAQ: REPL)
T. Rowe Price Associates, Inc. recently announced the acquisition of new stake in Replimune Group Inc (NASDAQ:REPL). The institutional investor has increased its shareholding in the Healthcare company by 0.94% to 5.67 million shares with purchase of 52966.0 shares. This fresh investment now brings its stake to 9.61% valued currently at $82.56 million. In addition, […]
